Microsoft word - curriculum vitae e v s - updated 2013.docx

CURRICULUM VITAE
Emmerentia Margaretha van Schalkwyk
M.B.,Ch.B. (U.S.), B.Sc.Med.Sc.Hons.(Epidemiology) (U.S.), Dip. Occ. Health (U.S.) Personal details :
First Language Afrikaans, Fluent in English ACADEMIC QUALIFICATIONS
Matriculated, La Rochel e Girls High School, Paarl BScMedScHons(Epidemiology), University of Stel enbosch Dip. Occupational Health, University of Stel enbosch EMPLOYMENT HISTORY
Medical Officer - Department of Medicine, Tygerberg Hospital Medical Officer - ENT Surgery, Tygerberg Hospital GP Practice Locum – Kraaifontein, and Maternity leave Medical Officer - ENT Surgery, Tygerberg Hospital Medical Officer - Pulmonology, Internal Medicine, Tygerberg Hospital Senior Medical Officer - Pulmonology, Internal Medicine, Tygerberg Hospital First Medical Officer - Pulmonology, Internal Medicine, Tygerberg Hospital Principle Medical Officer - Pulmonology, Internal Medicine, Tygerberg Hospital (including study leave from 01/2008 to 12/2008) Assistant (General Practitionar) at DR FH DE GOEDE Inc., Panorama Medical Center, Panorama ADDITIONAL POSITIONS HELD
Lecturer - Internal Medicine, University of Stel enbosch. Research Assistant, Respiratory Research Unit, University of Stel enbosch MEMBERSHIP/ REGISTRATION
South African Medical and Dental Council PAST MEMBERSHIP/ REGISTRATION
Department of Health – Dispensing License PAST PROFESSIONAL ACTIVITIES AT NATIONAL LEVEL
Technical committee, StanSA 5140.37G SPIROMETRY (SA Buro of Standards) South African Thoracic Society (SATS) Spirometry Standardisation Committee Surveil ance of Occupational Respiratory Disease in South Africa (SORDSA) Board of Directors SATS Council Member (University Representative) 2001 SATS Executive Council Member (Secretary) 2000 SATS Working Group for Chronic Obstructive Airways Disease 1998 PUBLICATIONS
1. L van der Merwe, A de Klerk, M Kidd, PG Bardin, EM van Schalkwyk. Case-control study of severe life threatening asthma (SLTA) in a developing community. Thorax 2006 Sep; 61(9): 756-60. 2. Van Schalkwyk, K. Strydom, Z. Wil iams, L. Venter, S. Leichtl, C. Schmid-Wirlitsch, D. Bredenbröker, P. G. Bardin. Roflumilast, an Oral, Once-Daily Phosphodiesterase 4 Inhibitor, attenuates allergen-induced asthmatic reactions. J Al ergy Clin Immunol 2005;116:292-8. 3. Van Schalkwyk EM, Schultz C, Joubert JR, White NW; South African Thoracic Society Standards of Spirometry Committee. Guideline for office spirometry in adults, 2004. S Afr Med J. 2004 Jul;94(7 Pt 2):576-87. PMID: 15283308 4. De Klerk A, van Schalkwyk E, Wil iams Z, Lee W, Bardin P. Risk factors for near-fatal asthma--a case-control study in a Western Cape teaching hospital. S Afr Med J. 2002 Feb;92(2):140-4. PMID: 11894651 5. Ferreira A, Wil iams Z, Donniger H, Van Schalkwyk E, Bardin P. Rhinovirus is associated with severe asthma exacerbations and raised nasal interleukin-12. Respiration 2002; 69(2):136-42. 6. Mattheyse FJ, Van Heerden K, Mattheyse M, Wil iams Z, Bouic P, Van Schalkwyk EM, Bardin PG. Reduced Activation of Peripheral Blood Neutrophils after Late Phase Asthmatic Responses but not in Mild Stable Asthma. Respiration. 2001; 68(5):471-9. 7. Esterhuizen TM, Rees D, Hnizdo E, Lal oo U Kielkowski D, Van Schalkwyk E, White N. Occupational Respiratory Disease Surveil ance in South Africa Part 2: Results from SORDSA (1997 to 1999). S Afr Med J 2001 Jun; 91(6): 502-8. 8. Bardin PG, Fraenkel DJ, Sanderson G, Van Schalkwyk EM, Holgate ST, Johnson SL. Peak Expiratory Flow Changes during Experimental Rhinovirus Infection. Eur Resp J 2000 Nov; 16(5): 980-5. 9. Working Group of the South African Pulmonology Society. Guidelines for the Management of Chronic Obstructive Pulmonary Disease. S Afr Med J 1998; 88: 999-101. 10. Wyser CP, Van Schalkwyk EM, Alheit B, Bardin PG, Joubert JR. Treatment of Progressive Pulmonary Sarcoidosis with Cyclosporin A. A Randomized Control ed Trial. Am J Respir Crit Care Med 1997 Nov; 156(5): 1371-6. 11. Wyser C, Walzl G, Smedema JP, Swart F, Van Schalkwyk EM, Van de Wal BW. Corticosteroids in the Treatment of Tuberculous Pleuricy. A double-blind, placebo-control ed, randomized study. Chest 1996 Aug; 110(2): 333-8. (Non-Peer-Reviewed)
1. Van Schalkwyk EM, Schultz C, Joubert JR, White NW; South African Thoracic Society Standards of Spirometry Committee. Guideline for office spirometry in adults. South African Respiratory Journal 2004; Vol 10, No 2: 48-63. (reprinted with permission from S Afr Med J July 2004; 94: 576-587). 2. Van Schalkwyk EM, Schultz C, Joubert JR, White NW; South African Thoracic Society Standards of Spirometry Committee. Guideline for office spirometry in adults. STELLMED, 2004. (reprinted with permission from S Afr Med J July 2004; 94: 576-587). 3. Van Schalkwyk EM. Hands-on Occupational Asthma. CME (Journal for Continuous INTERNATIONAL CONGRESS PRESENTATIONS/POSTERS (*Presenter)
1. E Van Schalkwyk*, C Lombard, N Beyers, E Bateman, and E Irusen. Risk factors for bronchial hyperresponsiveness in Cape Town, South Africa: Results from a community survey. European Respiratory Society Congress, Munchen, Germany, Sept 2006. 2. E Van Schalkwyk, C Lombard, N Beyers, E Bateman, and E Irusen*. Prevalence of bronchial hyperresponsiveness in a low-income urban area of Cape Town, South Africa. European Respiratory Society Congress, Copenhagen, Denmark, Sept 2005 3. E Van Schalkwyk, E Irusen*, C Lombard, A Jithoo, E Bateman, and N Beyers. Prevalence and treatment of asthma in persons 15-44 years old in a low income urban area of South Africa. European Respiratory Society Congress, Glasgow, Scotland, Sept 2004 4. EM van Schalkwyk*, K van Heerden, D Bredenbröker, S Leichtl, W Wurst, L. Venter, PG Bardin. Dose-Dependant Inhibitory Effect of Roflumilast, a New Oral y Active, Selective Phosphodiesterase 4 Inhibitor, on Allergen-Induced Early and Late Asthmatic Reaction. European Respiratory Society Congress, Stockholm, Sweden, Sept 2002 5. L van der Merwe*, A de Klerk, M Plaatjies, PG Bardin, EM van Schalkwyk. A Case-Control Study of Risk Factors for Adult Near-Fatal and Fatal Asthma in a Third-World Community. European Respiratory Society Congress, Stockholm, Sweden, Sept 2002 6. Van Schalkwyk EM*, Lombard L, Walzl G, Bardin PG. Atopy a Risk Factor for Pulmonary Tuberculosis. American Thoracic Society Congress, San Francisco, California, USA, May 2001. 7. De Klerk A*, Van Schalkwyk E, Wil iams Z, Lee W, Bardin P. Risk Factors for Near-Fatal Asthma: a Case-Control Study in a Western Cape Teaching Hospital. American Thoracic Society Congress, San Francisco, California, USA, May 2001 8. Van Schalkwyk EM*, Bezuidenhout J, Wyser CP, Van de Wal BW, Bardin PG, Joubert JR. Pulmonary Sarcoidosis: Effects of Cigarette Smoking. American Thoracic Society Congress, Chicago, Il inois, USA, May 1998. 9. Bardin PG*, Fraenkel DJ, Sanderson G, Van Schalkwyk EM, Johnson SL, Holgate ST. Peak Expiratory Flow Changes during Experimental Rhinovirus Infection. American Thoracic Society Congress, Chicago, Il inois, USA, May 1998. 10. Van Schalkwyk EM*, Bezuidenhout J, Wyser CP, Bardin PG, Joubert JR. Comparison of Bronchoalveolar Lavage, Open Lung Biopsy and Lung Function in Sarcoidosis. European Respiratory Society Congress, Berlin, Germany, Sept 1997. 11. Van Schalkwyk EM*, Amukoye E, Adungosi JE, Kwamanga D. Presentation of Winning Protocol: Smoking Prevalence in High School Children and Teachers in Nairobi. International Course on Research Methods for the Promotion of Lung Health, Nairobi, Kenya, December 1996. 12. Van Schalkwyk EM*, Wyser CP, Alheit B, Bardin PG, Joubert JR. Treatment of Chronic Sarcoidosis with Cyclosporin. American Thoracic Society Congress, New Orleans, Louisianna, USA, May 1996. 13. Walzl G, Wyser CP, Smedema JP, Swart F, Van Schalkwyk EM*, Van de Wal BW. Corticosteroids in the Treatment of Tuberculous Pleuricy. American Thoracic Society Congress, New Orleans, Louisianna, May 1996. LOCAL CONGRESS PRESENTATIONS
1. E Van Schalkwyk, C Lombard, N Beyers, E Bateman, and E Irusen*. Prevalence of bronchial hyperresponsiveness in a low-income urban area of Cape Town, South Africa. S A Thoracic and Critical Care Society Congress, Sun City, Pilansberg, 2005. 2. E Van Schalkwyk, E Irusen*, C Lombard, A Jithoo, E Bateman, and N Beyers. Prevalence and treatment of asthma in persons 15-44 years old in a low income urban area of South Africa. S A Thoracic and Critical Care Society Congress, Cape Town, 2004 3. L van der Merwe, A de Klerk*, M Plaatjies, PG Bardin, EM van Schalkwyk. A Case-Control Study of Risk Factors for Adult Near-Fatal and Fatal Asthma in a Third-World Community. S A Thoracic and Critical Care Society Congress (COPICON 2002), Sun City, Pilansberg, July 2002. 4. EM van Schalkwyk* on behalf of The South African Thoracic Society Spirometry Standardisation Working Group. 2001 Guidelines for standardised spirometry in South Africa. S A Thoracic and Critical Care Society Congress, Bloemfontein, July 2001. 5. De Klerk A*, Van Schalkwyk E, Wil iams Z, Lee W, Bardin P. Risk Factors for Near-Fatal Asthma: a Case-Control Study in a Western Cape Teaching Hospital. S A Thoracic and Critical Care Society Congress, Bloemfontein, July 2001. 6. Van Schalkwyk EM*, Lombard L, Walzl G, Bardin PG. Association between Tuberculosis and Atopy. S A Pulmonology and Critical Care Society Congress (COMCO 2000), Durban, July 2000. 7. Van Schalkwyk EM*, Bezuidenhout J, Wyser CP, Bardin PG and Joubert JR. Descriptive Study of Pulmonary Sarcoidosis in Smokers and Non-Smokers. SAPS Congress, Wild Coast Sun, March 1999. 8. Van Schalkwyk EM*, Wyser CP, Bezuidenhout J, Bardin PG, Joubert JR. Comparison of Bronchoalveolar Lavage, Open Lung Biopsy and Pulmonary Function in Sarcoidosis. South African Pulmonology Society Congress, Windhoek, August 1997. 9. Buttner Z*, Van Eeden A, Van Schalkwyk EM, Du Toit M, Joubert JR. Lung Function in Patients with Schleroderma and Exertional Dyspnoea. South African Pulmonology Society Congress, Windhoek, August 1997. 10. Louw CM*, Nell H, Van Schalkwyk EM, Joubert JR, Bardin PG. The Broncho-dilator Response to Salbutamol and Ipratropium Bromide in Asthmatics. South African Pulmonology Society Congress, Windhoek, August 1997. 11. Van Schalkwyk EM*, Wyser CP, Bardin PG, Joubert JR. Treatment of Chronic Sarcoidosis with Cyclosporin. South African Pulmonology Society Congress, Wilderness, March 1996. 12. Joubert JR*, Van Schalkwyk EM, Pretorius J, De Kock MA, Swiegers W. The Influence of Environmental Factors on the Lung Health of Workers at a Uranium Mine. South African Pulmonology Congress, Wilderness, March 1996. 13. Joubert JR*, Van Schalkwyk EM, Bol iger CT, Jones E. Inspiratory and Exspiratory Lung Functions in Asthmatic and Normal Individuals. South African Pulmonology Congress, Wild Coast Sun, April 1993. 14. Van Schalkwyk EM*, Van Eeden SF. Blunt Chest Trauma: Grading the Severity of Injury. South African Pulmonology Society Congress, Sun City, March 1990. 15. Van Schalkwyk EM*, Van Eeden SF. Complicated Varicel a Pneumonia in Adults. South African Pulmonology Society Congress, Wilderness, September 1988. 1. European Respiratory Society Bronze Sponsorship (2006): E Van Schalkwyk, C Lombard, N Beyers, E Bateman, and E Irusen Risk factors for bronchial hyperresponsiveness in Cape Town, South Africa: Results from a community survey. 2. European Respiratory Society Bronze Sponsorship (2005): E Van Schalkwyk, C Lombard, N Beyers, E Bateman, and E Irusen. Prevalence of bronchial hyperresponsiveness in a low-income urban area of Cape Town, South Africa. 3. Best poster – Internal Medicine Academic Year Day (2005): E Van Schalkwyk, C Lombard, N Beyers, E Bateman, and E Irusen. Prevalence of bronchial hyperresponsiveness in a low-income urban area of Cape Town, South Africa. 4. European Respiratory Society Merit Award (2002): A Case-Control Study of Risk Factors for Adult Near-Fatal and Fatal Asthma in a Third-World Community. L van der Merwe, A de Klerk, M Plaatjies, PG Bardin, EM van Schalkwyk 5. SA Thoracic Society Junior Investigator Award (2001): De Klerk A, Van Schalkwyk E, Wil iams Z, Lee W, Bardin P. Risk Factors for Near-Fatal Asthma: a Case-Control Study in a Western Cape Teaching Hospital. 6. SA Pulmonology Society Best Publication Award (1999): Wyser CP, Van Schalkwyk EM, Alheit B, Bardin PG, Joubert JR. Treatment of Progressive Pulmonary Sarcoidosis with Cyclosporin A. A Randomized Control ed Trial. Am J Respir Crit Care Med 1997 Nov; 156(5): 1371-6. 7. IUATLD Course on Research Methods Best Protocol Award (1996): Van Schalkwyk EM, Amukoye E, Adungosi JE, Kwamanga D. Smoking Prevalence in High School Children and Teachers in Nairobi. RESEARCH GRANTS AWARDED
1. Allergy Society of SA / Glaxo SmithKline (2005) 3. Allergy Society of SA / Glaxo Wel come (1998)

Source: http://www.skinlogic.co.za/images/Emmerntia%20M%20van%20Schalkwyk%20CV.pdf